New product solution applicable to orthopedic repair surgeries. The new technology is far superior to the materials currently in use and, as a result, the end products that the market offers. The technology used makes it possible to obtain a material characterized by high durability and strength which is much greater than nature.

 

Developed production technology to obtain a high quality product at a low cost. The company has already started small-scale production and is generating revenue from the sale of products in the medical related industry.

 

The solution already preliminarily proven in medicine is protected by patents in the EU and USA.

 

Very large market and opportunities for high margin.

Options for sale are investment in exchange for shares in the company or sale of a license. 

Expected price for a share in the company to be negotiated.

Sale of a license:

- for the EU territory - €3 million

- for the territory of the USA - $5 million